Letter of the editor| Volume 24, ISSUE 3, P468-469, March 2002

Dear Dr. Walson:

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Therapeutics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Zhao SZ
        • Reynolds MW
        • Lefkowith J
        • et al.
        A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre Safety Database.
        Clin Ther. 2001; 23: 1478-1491
      1. Prescription data. IMS Health Web site. Available at:

        • Garcia Rodriguez LA
        • Varas C
        • Patrono C
        Differential effects of aspirin and non-aspirin non-steroidal antiinflammatory drugs in the primary prevention of myocardial infarction in post-menopausal women.
        Epidemiology. 2000; 11: 382-387
        • Steering Committee of the Physicians' Health Study Research Group
        Final report on the aspirin component of the ongoing Physicians' Health Study.
        N Engl J Med. 1989; 321: 129-135